The Crooks of CRUK
Cancer Research UK is a charity which relies on donations, volunteer work and fundraising. What if these citizens knew their money goes to fund bad science?
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Cancer Research UK is a charity which relies on donations, volunteer work and fundraising. What if these citizens knew their money goes to fund bad science?
Oxford professor Dame Kay E Davies, DBE FRS FMedSci, edits the journal Human Molecular Genetics. If you are a scientist who likes Photoshop, but afraid to get caught, give Dame Kay a call!
Liverpool professor Patricia Murray continues investigating shady dealings of the regmed company Celixir, owned by struck-off dentist Ajan Reginald and Nobelist Sir Martin Evans
I publish exclusively two uncensored UCL screening panel reports into the David Latchman and Anastasis Stephanou affair. Now we know which papers were investigated and which requested retractions didn’t happen.
Get ready to meet Dr Richard Hill and his amazing jumping blots. Just don’t stare, or you’ll get hurt.
In David Latchman affair, UCL finally gave censored investigative reports to journalists. These show the Master of Birkbeck was found guilty of misconduct by recklessness, trice. Former investigator John Hardy now speaks out exclusively on my site.
The University of Manchester found out that someone has secretly manipulated data in the papers of their star cancer researcher, Richard Marais. Who might that be?
Irina Stancheva was investigated in Edinburgh for fraud at least twice, in 2009 and 2017, yet retraction and correction decisions were not implemented. Apparently to protect the reputation of Nobel Prize candidate Sir Adrian Bird and his male mentees, primarily Richard Meehan. One wonders: how much of Bird research in past two decades was actually fabricated by Stancheva?
Sir Martin Evans, winner of Nobel prize 2007, founded in 2009 the stem cell start-up Celixir, together with a struck-off dentist Ajan Reginald. With the help of the British heart surgeon Stephen Westaby, they ran a very profitable clinical trial in Greece, which now moved into UK.
The 2008 Lancet paper of Paolo Macchiarini and Martin Birchall about the world first trachea transplant might end up retracted. Until recently, the journal’s editor Richard Horton used to ignore and suppress “non peer-reviewed” evidence, but due to combined pressure of activism, media and politics, things started to move.









